Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: A longitudinal study

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 2, 2004, Pages 383-385

  Lamfon, Hanadi ^a   Porter, Stephen R ^a   McCullough, Michael ^b   Pratten, Jonathan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antifungal; Antimicrobial; In vitro; MIC

Indexed keywords

ACRYLIC ACID DERIVATIVE; ANTIFUNGAL AGENT; CHLORHEXIDINE GLUCONATE; FLUCONAZOLE; MICONAZOLE; SALIVA SUBSTITUTE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOFILM REACTOR; CANDIDA ALBICANS; CELL GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DENTURE; FUNGUS GROWTH; IN VITRO STUDY; INCUBATION TIME; LONGITUDINAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUTH CAVITY; NONHUMAN; YEAST CELL;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CHLORHEXIDINE; COLONY COUNT, MICROBIAL; DISINFECTANTS; FERMENTATION; FLUCONAZOLE; LONGITUDINAL STUDIES; MICONAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 1242330005     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh071     Document Type: Article

References (10)

1. Gilbert, P., Das, J. & Foley, I. (1997). Biofilm susceptibility to antimicrobials. Advances in Dental Research 11, 160-7.
2. Donlan, R. M. & Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clinical Microbiology Reviews 15, 167-93.
3. Wilson, M. (2001). Bacterial biofilms and human disease. Science Progress 84, 235-54.
4. Baillie, G. S. & Douglas, L. J. (2000). Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. Journal of Antimicrobial Chemotherapy 46, 397-403.
5. Mukherjee, P. K., Chandra, J., Kuhn, D. M. et al. (2003). Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infection and Immunity 71, 4333-40.
6. Chandra, J., Kuhn, D. M., Mukherjee, P. K. et al. (2001). Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. Journal of Bacteriology 183, 5385-94.
7. Al-Karaawi, Z. M., Manfredi, M., Waugh, A. C. et al. (2002). Molecular characterization of Candida spp. isolated from the oral cavities of patients from diverse clinical settings. Oral Microbiology and Immunology 17, 44-9.
8. Pratten, J., Smith, A. W. & Wilson, M. (1998). Response of single species biofilms and microcosm dental plaques to pulsing with chlorhexidine. Journal of Antimicrobial Chemotherapy 42, 453-59.
9. National Committee for Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. NCCLS, Villanova, PA, USA.
10. Ramage, G., VandeWalle, K., Bachmann, S. P. et al. (2002). In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrobial Agents and Chemotherapy 46, 3634-6.